SCHEMBL13938155

SCHEMBL13938155

Cc1ccccc1-c1nc(Nc2n[nH]c3ccc(F)cc23)c2ccccc2n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 11/20 0.54
CYP3A4 P08684 10/20 0.54
HSD17B10 Q99714 9/20 0.54
CYP2D6 P10635 8/20 0.54
CLK4 Q9HAZ1 6/20 0.54
ALOX15 P16050 4/20 0.54
CYP2C19 P33261 4/20 0.54
USP2 O75604 3/20 0.54
ALDH1A1 P00352 5/20 0.54
LMNA P02545 3/20 0.54
TSHR P16473 4/20 0.49
MAPK1 P28482 3/20 0.49
KDM4E B2RXH2 2/20 0.49
MAPT P10636 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
GLA P06280 1/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
CYP2C9 P11712 1/20 0.47
AURKA O14965 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL785479 0.89 CYP1A2 (0.61) CYP1A2CYP3A4HSD17B10CYP2D6CLK4
SCHEMBL801914 0.88 FADS1 (0.49) CYP1A2CYP3A4HSD17B10CYP2D6CLK4
SCHEMBL801510 0.87 FADS1 (0.46) CYP1A2CYP3A4HSD17B10CYP2D6CLK4
SCHEMBL10268959 0.87 USP1 (0.47) CYP1A2CYP3A4HSD17B10CYP2D6CLK4
SCHEMBL786490 0.87 CYP1A2 (0.54) CYP1A2CYP3A4HSD17B10CYP2D6CLK4
SCHEMBL1083862 0.86 USP1 (0.48) CYP1A2CYP3A4HSD17B10CYP2D6CLK4
SCHEMBL801544 0.86 USP1 (0.52) CYP1A2CYP3A4HSD17B10CYP2D6CLK4
SCHEMBL785611 0.85 ABCG2 (0.60) ALDH1A1LMNAKDM4EMAPTMEN1
SCHEMBL13107211 0.85 USP1 (0.45) CYP1A2CYP3A4HSD17B10CYP2D6CLK4
SCHEMBL786256 0.85 USP1 (0.64) CYP1A2CYP3A4HSD17B10CYP2D6CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7473691-B2 Pyrazole compounds useful as protein kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-01-06 US disclosed